Related Experiment Videos
Cost-effective pharmacotherapy for inhalant allergic rhinitis
1Division of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, NY 14618, USA. enthadley@aol.com
Otolaryngologic Clinics of North America
|January 28, 2004
Summary
For respiratory allergy relief, intranasal corticosteroids are often preferred for chronic cases, while second-generation antihistamines offer better tolerance and fewer side effects than older options.
Area of Science:
- Otolaryngology
- Allergy and Immunology
- Pharmacology
Background:
- Respiratory allergies significantly impact patients' quality of life and well-being.
- Patients seek effective symptom relief with minimal side effects.
Purpose of the Study:
- To review treatment options for allergic rhinitis.
- To compare the efficacy and side-effect profiles of different allergy medications.
Main Methods:
- Review of current medical literature on allergic rhinitis treatments.
- Comparison of first-generation and second-generation antihistamines.
- Evaluation of intranasal corticosteroids and other therapies.
Main Results:
- Second-generation antihistamines offer improved tolerance and reduced sedation compared to first-generation drugs.
- Intranasal corticosteroids are frequently prescribed as first-line treatment for chronic allergic rhinitis.
- Oral antihistamines, topical cromolyn, and short-term decongestants are suitable for sporadic or limited allergic conditions.
Conclusions:
- Treatment choice for allergic rhinitis depends on chronicity and exposure.
- Second-generation antihistamines provide a favorable alternative to first-generation options.
- Intranasal corticosteroids remain a primary therapeutic strategy for persistent allergic rhinitis.